CYCLOPHOSPHAMIDE, Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion., DOXORUBICIN, DOCETAXEL
UC-0103/1102
Phase 3 small_molecule active
Quick answer
CYCLOPHOSPHAMIDE, Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion., DOXORUBICIN, DOCETAXEL for oestrogen-receptor (ER)-positive HER2-negative breast carcinoma is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- oestrogen-receptor (ER)-positive HER2-negative breast carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active